A Alpérovitch

4.0k total citations · 1 hit paper
50 papers, 3.0k citations indexed

About

A Alpérovitch is a scholar working on Molecular Biology, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A Alpérovitch has authored 50 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Psychiatry and Mental health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A Alpérovitch's work include Prion Diseases and Protein Misfolding (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). A Alpérovitch is often cited by papers focused on Prion Diseases and Protein Misfolding (9 papers), Dementia and Cognitive Impairment Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). A Alpérovitch collaborates with scholars based in France, Spain and Netherlands. A Alpérovitch's co-authors include Christophe Tzourio, D. Villers, Paul E.A. Glaser, C. Granthil, Daniel Mathieu, Philippe Mercier, Jean‐Roger Le Gall, Alexis Elbaz, Carole Dufouil and Rebecca Fuhrer and has published in prestigious journals such as The Lancet, Neurology and Gut.

In The Last Decade

A Alpérovitch

48 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A simplified acute physiology score for ICU patients

1984 954 citations A Alpérovitch et al. profile →

Peers

A Alpérovitch

EPIDE

PMH

MB

NEURO

CCM

Kathryn Richardson United Kingdom

Angelo E. Canonico United States

J Greene United States

M Britton Sweden

Christine Roffe United Kingdom

Nathalie de Rekeneire United States

Armando Teixeira‐Pinto Australia

Catriona Graham United Kingdom

Joseph Kwan United Kingdom

Andy Jagoda United States

Kathryn Richardson United Kingdom

A Alpérovitch

710 ×1.1

EPIDE

622 ×1.0

PMH

373 ×0.7

MB

223 ×0.5

NEURO

587 ×1.5

CCM

Citations per year, relative to A Alpérovitch A Alpérovitch (= 1×) peers Kathryn Richardson

Countries citing papers authored by A Alpérovitch

Since Specialization

Citations

This map shows the geographic impact of A Alpérovitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Alpérovitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Alpérovitch more than expected).

Fields of papers citing papers by A Alpérovitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Alpérovitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Alpérovitch. The network helps show where A Alpérovitch may publish in the future.

Co-authorship network of co-authors of A Alpérovitch

This figure shows the co-authorship network connecting the top 25 collaborators of A Alpérovitch. A scholar is included among the top collaborators of A Alpérovitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Alpérovitch. A Alpérovitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hanon, Olivier, et al.. (2011). RISK OF SUSTAINED HYPERTENSION IN MASKED AND WHITE-COAT HYPERTENSION: A FOLLOW-UP STUDY OF AN ELDERLY COMMUNITY-BASED COHORT. Journal of Hypertension. 29. e294–e295.

2.

Dumurgier, Julien, Alexis Elbaz, Pierre Ducimetière, et al.. (2009). Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ. 339(nov10 2). b4460–b4460. 258 indexed citations

3.

Tzourio, Christophe, Bertrand Gagnière, Mehdi El Amrani, Bousser Mg, & A Alpérovitch. (2003). Lay versus expert interviewers for the diagnosis of migraine in a large sample of elderly people. Journal of Neurology Neurosurgery & Psychiatry. 74(2). 238–241. 17 indexed citations

4.

Launer, Lenore J., Matthijs Oudkerk, Lars‐Göran Nilsson, et al.. (2000). CASCADE: A European Collaborative Study on Vascular Determinants of Brain Lesions. Neuroepidemiology. 19(3). 113–120. 35 indexed citations

5.

Aylin, Paul, et al.. (1999). Mortality from dementia in occupations at risk of exposure to bovine spongiform encephalopathy: analysis of death registrations Commentary: Uncertainty over length of incubation tempers optimism. BMJ. 318(7190). 1044–1045. 2 indexed citations

6.

Paterniti, Sabrina, Carole Dufouil, J.C. Bisserbe, & A Alpérovitch. (1999). Anxiety, depression, psychotropic drug use and cognitive impairment. Psychological Medicine. 29(2). 421–428. 41 indexed citations

7.

d’Aignaux, Jérôme Huillard, Dominique Costagliola, Jean Maccario, et al.. (1999). Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France. Neurology. 53(6). 1197–1197. 62 indexed citations

8.

Delasnerie–Lauprêtre, N., Carlo Masullo, Inga Zerr, et al.. (1998). Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. The Lancet. 351(9109). 1081–1085. 139 indexed citations

9.

Tzourio, Christophe, Walter A. Rocca, Monique M.B. Breteler, et al.. (1997). Smoking and Parkinson's disease. Neurology. 49(5). 1267–1272. 48 indexed citations

10.

Delasnerie–Lauprêtre, N., Isabelle Jaussent, Dominique Dormont, et al.. (1997). [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995].. PubMed. 45(6). 448–53. 5 indexed citations

11.

Villemeur, T Billette de, J.P. Deslys, A Alpérovitch, et al.. (1996). Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 47(3). 690–695. 52 indexed citations

12.

Dufouil, Carole, Rebecca Fuhrer, Jean‐François Dartigues, & A Alpérovitch. (1996). Longitudinal Analysis of the Association between Depressive Symptomatology and Cognitive Deterioration. American Journal of Epidemiology. 144(7). 634–641. 151 indexed citations

13.

Tzourio, Christophe, Alain Djacoba Tehindrazanarivelo, S. Iglesias, et al.. (1995). Case-control study of migraine and risk of ischaemic stroke in young women. BMJ. 310(6983). 830–833. 353 indexed citations

14.

Tison, François, J.-F. Dartigues, Sophie Auriacombe, et al.. (1995). Dementia in Parkinson's disease. Neurology. 45(4). 705–708. 69 indexed citations

15.

Fuhrer, Rebecca, Toni C. Antonucci, Marc‐André Gagnon, et al.. (1992). Depressive symptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France. Psychological Medicine. 22(1). 159–172. 89 indexed citations

16.

Berr, Claudine, et al.. (1989). Absence of familial association between dementia of Alzheimer type and down syndrome. American Journal of Medical Genetics. 33(4). 545–550. 6 indexed citations

17.

Billiard, Michel, et al.. (1987). Excessive Daytime Somnolence in Young Men: Prevalence and Contributing Factors. SLEEP. 10(4). 297–305. 61 indexed citations

18.

Girardin, Marc, et al.. (1985). Computer-aided selection of diagnostic tests in jaundiced patients.. Gut. 26(9). 961–967. 12 indexed citations

19.

Alpérovitch, A. (1983). Controlled assessment of diagnostic techniques: methodological problems.. PubMed. 1(4). 187–90. 5 indexed citations

20.

Alpérovitch, A, F T de Dombal, & F Grémy. (1979). Evaluation of efficacy of medical action. North-Holland eBooks. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact